Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice

被引:41
|
作者
Zhang, D. [1 ]
Shimizu, T. [1 ]
Araki, N. [1 ]
Hirota, T. [2 ]
Yoshie, M. [3 ]
Ogawa, K. [3 ]
Nakagata, N. [4 ]
Takeya, M. [5 ]
Saya, H. [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto, Japan
[2] Japanese Fdn Canc Res, Inst Canc, Dept Expt Pathol, Tokyo 170, Japan
[3] Asahikawa Med Coll, Dept Pathol, Asahikawa, Hokkaido 078, Japan
[4] Kumamoto Univ, Ctr Anim Resources & Dev, Div Reprod Engn, Kumamoto, Japan
[5] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan
关键词
Aurora A; polyploidy; apoptosis; senescence; p16; DNA damage;
D O I
10.1038/onc.2008.76
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aurora A mitotic kinase is frequently overexpressed in various human cancers and is widely considered to be an oncoprotein. However, the cellular contexts in which Aurora A induces malignancy in vivo are still unclear. We previously reported a mouse model in which overexpression of human Aurora A in the mammary gland leads to small hyperplastic changes but not malignancy because of the induction of p53-dependent apoptosis. To study the additional factors required for Aurora A-associated tumorigenesis, we generated a new Aurora A overexpression mouse model that lacks p53. We present evidence here that Aurora A overexpression in primary mouse embryonic fibroblasts (MEFs) that lack p53 overrides postmitotic checkpoint and leads to the formation of multinucleated polyploid cells. Induction of Aurora A overexpression in the mammary glands of p53-deficient mice resulted in development of precancerous lesions that were histologically similar to atypical ductal hyperplasia in human mammary tissue and showed increased cellular senescence and p16 expression. We further observed DNA damage in p53-deficient primary MEFs after Aurora A overexpression. Our results suggest that Aurora A overexpression in mammary glands is insufficient for the development of malignant tumors in p53-deficient mice because of the induction of cellular senescence. Both p53 and p16 are critical in preventing mammary gland tumorigenesis in the Aurora A overexpression mouse model.
引用
收藏
页码:4305 / 4314
页数:10
相关论文
共 43 条
  • [31] Oocyte-based screening of cytokinesis inhibitors and identication of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors
    Chae, HD
    Choi, TS
    Kim, BM
    Jung, JH
    Bang, YJ
    Shin, DY
    ONCOGENE, 2005, 24 (30) : 4813 - 4819
  • [32] Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors
    Hee-Don Chae
    Tae-Saeng Choi
    Byeong-Mo Kim
    Jee H Jung
    Yung-Jue Bang
    Deug Y Shin
    Oncogene, 2005, 24 : 4813 - 4819
  • [33] SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors
    Tzeng, YJ
    Zimmermann, C
    Guhl, E
    Berg, B
    Avantaggiati, ML
    Graessmann, A
    ONCOGENE, 1998, 16 (16) : 2103 - 2114
  • [34] SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors
    Y J Tzeng
    C Zimmermann
    E Guhl
    B Berg
    M L Avantaggiati
    A Graessmann
    Oncogene, 1998, 16 : 2103 - 2114
  • [35] PREFERENTIAL OVEREXPRESSION OF A 172(ARG-]LEU) MUTANT P53 IN THE MAMMARY-GLAND OF TRANSGENIC MICE RESULTS IN ALTERED LOBULOALVEOLAR DEVELOPMENT
    LI, BL
    GREENBERG, N
    STEPHENS, LC
    MEYN, R
    MEDINA, D
    ROSEN, JM
    CELL GROWTH & DIFFERENTIATION, 1994, 5 (07): : 711 - 721
  • [36] Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway
    Akli, Said
    Van Pelt, Carolyn S.
    Bui, Tuyen
    Multani, Asha S.
    Chang, Sandy
    Johnson, David
    Tucker, Susan
    Keyomarsi, Khandan
    CANCER RESEARCH, 2007, 67 (15) : 7212 - 7222
  • [37] The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in p53-Null Mammary Gland Mice
    Mazumdar, Abhijit
    Medina, Daniel
    Kittrell, Francis S.
    Zhang, Yun
    Hill, Jamal L.
    Edwards, David E.
    Bissonnette, Reid P.
    Brown, Powel H.
    CANCER PREVENTION RESEARCH, 2012, 5 (10) : 1195 - 1202
  • [38] Expression pattern of the cell adhesion molecules E-cadherin, P-cadherin and alpha 6 beta 3 integrin is altered in pre-malignant skin tumors of p53-deficient mice
    Cano, A
    Gamallo, C
    Kemp, CJ
    Benito, N
    Palacios, J
    Quintanilla, M
    Balmain, A
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (02) : 254 - 262
  • [39] Haploidinsufficiency of p53 rescues cellular deficiency and promotes mammary gland tumor formation in Brca1 exon 11-isoform knockout mice
    Xu, XL
    Linke, SP
    Harris, CC
    Deng, CX
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 431A - 431A
  • [40] Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
    Liu, Xiaoling
    Holstege, Henne
    van der Gulden, Hanneke
    Treur-Mulder, Marcelle
    Zevenhoven, John
    Velds, Arno
    Kerkhoven, Ron M.
    van Vliet, Martin H.
    Wessels, Lodewyk F. A.
    Peterse, Johannes L.
    Berns, Anton
    Jonkers, Jos
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (29) : 12111 - 12116